This year has witnessed substantial advances in receptor biology and signal
transduction that are relevant to the function and regulation of the healt
hy pancreas and to the pathogenesis and potential therapy of pancreatitis a
nd pancreatic carcinoma. There has been an expansion in the cast of pancrea
tic regulatory molecules, now including protease-activated receptors, chemo
kines, and chemokine receptors. There have been new insights into the cellu
lar distribution and signaling initiated at the classic pancreatic receptor
s. There have also been dramatic advances in insights into the structure of
G protein-coupled receptors, with the first solution of a crystal structur
e of a member of this superfamily, and into the molecular basis of ligand b
inding and activation of these important molecules. This will clearly impro
ve the opportunities for the rational design and refinement of receptor-act
ive drugs. In addition to these fundamental advances, there has been renewe
d attention to the expression, function, and regulation of receptors and si
gnaling pathways in pancreatic cells present in the setting of pancreatitis
and pancreatic carcinoma. It is hoped that this will contribute toward ear
lier diagnosis, more successful therapy, and new chemopreventive strategies
for these illnesses. Curr Opin Gastroenterol 2001, 17:410-415 (C) 2001 Lip
pincott Williams & Wilkins, Inc.